Submitted by Anonymous (not verified) on 17 July 2025 - 14:01
Orphan designation: utreloxastat Treatment of amyotrophic lateral sclerosis, 09/12/2022 Withdrawn
Source:
Orphan designation: utreloxastat Treatment of amyotrophic lateral sclerosis, 09/12/2022 Withdrawn